ANVISA-2020-0065-V265
Type IB variation for application ANVISA-2020-0065. Type IB variation: Facility Change for Tisagenlecleux-B — minor update
Variation Number
ANVISA-2020-0065-V265
Type
Type IB
Application
Change
Status
Draft
Fee
€1,834
Submitted
2022-12-07
Approved
—
Description
Type IB variation: Facility Change for Tisagenlecleux-B — minor update